New Public Citizen Health Lead To Keep Banging Drum On Stronger Benefit-Risk Ratios
Executive Summary
Robet Steinbrook, the third director of the 50-year-old health group, plans to stay true to the organization’s long-held mission of holding FDA drug approvals to high standards, pushing for stronger evidence of benefit, more attention to safety, and advisory committee votes.